Arcadia Biosciences's total assets for Q2 2026 were $5.89M, an increase of 10.71% from the previous quarter. DE:17D total liabilities were $5.26M for the fiscal quarter, a 115.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.